GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (NAS:NTRB) » Definitions » Scaled Net Operating Assets

Nutriband (Nutriband) Scaled Net Operating Assets : 0.73 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Nutriband Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nutriband's operating assets for the quarter that ended in Jan. 2024 was $7.02 Mil. Nutriband's operating liabilities for the quarter that ended in Jan. 2024 was $0.84 Mil. Nutriband's Total Assets for the quarter that ended in Oct. 2023 was $8.52 Mil. Therefore, Nutriband's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2024 was 0.73.


Nutriband Scaled Net Operating Assets Historical Data

The historical data trend for Nutriband's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutriband Scaled Net Operating Assets Chart

Nutriband Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 0.17 3.98 0.72 0.53 0.65

Nutriband Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.71 0.79 0.68 0.73

Competitive Comparison of Nutriband's Scaled Net Operating Assets

For the Biotechnology subindustry, Nutriband's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutriband's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nutriband's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Nutriband's Scaled Net Operating Assets falls into.



Nutriband Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Nutriband's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jan. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jan. 2024 )
=(Operating Assets (A: Jan. 2024 )-Operating Liabilities (A: Jan. 2024 ))/Total Assets (A: Jan. 2023 )
=(7.024-0.838)/9.456
=0.65

where

Operating Assets(A: Jan. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=7.517 - 0.493
=7.024

Operating Liabilities(A: Jan. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.079 - 0.08 - 0.161
=0.838

Nutriband's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jan. 2024 )
=(Operating Assets (Q: Jan. 2024 )-Operating Liabilities (Q: Jan. 2024 ))/Total Assets (Q: Oct. 2023 )
=(7.024-0.838)/8.523
=0.73

where

Operating Assets(Q: Jan. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=7.517 - 0.493
=7.024

Operating Liabilities(Q: Jan. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.079 - 0.08 - 0.161
=0.838

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutriband Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Nutriband's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutriband (Nutriband) Business Description

Industry
Traded in Other Exchanges
Address
121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Executives
Michael Davidov director 60 EAST 42 STREET, NEW YORK NY 10165
Serguei Melnik director, 10 percent owner, officer: Chief Financial Officer
Gareth Sheridan director, 10 percent owner, officer: CEO 6064 CENTRAL COLLEGE RD., NEW ALBANY OH 43054
Vitalie Botgros director, 10 percent owner, officer: Chairman of the BOD GREGERSTR 36B, FISHAMEND C4 2401

Nutriband (Nutriband) Headlines